BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 28771870)

  • 41. Evaluating sleepiness-related daytime function by querying wakefulness inability and fatigue: Sleepiness-Wakefulness Inability and Fatigue Test (SWIFT).
    Sangal RB
    J Clin Sleep Med; 2012 Dec; 8(6):701-11. PubMed ID: 23243405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From wakefulness to excessive sleepiness: what we know and still need to know.
    Ohayon MM
    Sleep Med Rev; 2008 Apr; 12(2):129-41. PubMed ID: 18342261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias.
    Pizza F; Filardi M; Moresco M; Antelmi E; Vandi S; Neccia G; Mazzoni A; Plazzi G
    Sleep Breath; 2020 Jun; 24(2):605-614. PubMed ID: 31154621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. P300 latency: abnormal in sleep apnea with somnolence and idiopathic hypersomnia, but normal in narcolepsy.
    Sangal RB; Sangal JM
    Clin Electroencephalogr; 1995 Jul; 26(3):146-53. PubMed ID: 7554301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subjective and Objective Assessment of Hypersomnolence.
    Murray BJ
    Sleep Med Clin; 2017 Sep; 12(3):313-322. PubMed ID: 28778230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Daytime variation in performance and tiredness/sleepiness ratings in patients with insomnia, narcolepsy, sleep apnea and normal controls.
    Schneider C; Fulda S; Schulz H
    J Sleep Res; 2004 Dec; 13(4):373-83. PubMed ID: 15560772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.
    Littner MR; Kushida C; Wise M; Davila DG; Morgenthaler T; Lee-Chiong T; Hirshkowitz M; Daniel LL; Bailey D; Berry RB; Kapen S; Kramer M;
    Sleep; 2005 Jan; 28(1):113-21. PubMed ID: 15700727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
    Razmy A; Lang AE; Shapiro CM
    Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
    Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
    Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disorders of excessive sleepiness: narcolepsy and hypersomnia.
    Manfredi RL; Brennan RW; Cadieux RJ
    Semin Neurol; 1987 Sep; 7(3):250-8. PubMed ID: 3332460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple sleep latency test and maintenance of wakefulness test.
    Sullivan SS; Kushida CA
    Chest; 2008 Oct; 134(4):854-861. PubMed ID: 18842919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brief and distinct empirical sleepiness and fatigue scales.
    Bailes S; Libman E; Baltzan M; Amsel R; Schondorf R; Fichten CS
    J Psychosom Res; 2006 Jun; 60(6):605-13. PubMed ID: 16731235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypersomnolence and narcolepsy; a pragmatic diagnostic neurophysiological approach.
    Boon P; Pevernagie D; Schrans D
    Acta Neurol Belg; 2002 Mar; 102(1):11-8. PubMed ID: 12094557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different fates of excessive daytime sleepiness: survival analysis for remission.
    Kim T; Lee JH; Lee CS; Yoon IY
    Acta Neurol Scand; 2016 Jul; 134(1):35-41. PubMed ID: 26392230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT)].
    Nakamura H; Takara C; Yamashiro K; Nakamura C; Okada T; Tohyama K
    Nihon Rinsho; 2009 Aug; 67(8):1569-75. PubMed ID: 19768942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On-the-road driving performance of patients with central disorders of hypersomnolence.
    van der Sluiszen NNJJM; Urbanus B; Lammers GJ; Overeem S; Ramaekers JG; Vermeeren A
    Traffic Inj Prev; 2021; 22(2):120-126. PubMed ID: 33543997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlations between subjective and objective features of nocturnal sleep and excessive diurnal sleepiness in patients with narcolepsy.
    Jiménez-Correa U; Haro R; Obdulia González R; Velázquez-Moctezuma J
    Arq Neuropsiquiatr; 2009 Dec; 67(4):995-1000. PubMed ID: 20069207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Wake disorders. I. Primary wake disorders].
    Billiard M; Carlander B
    Rev Neurol (Paris); 1998 Feb; 154(2):111-29. PubMed ID: 9773032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Actigraphic assessment of sleep/wake behavior in central disorders of hypersomnolence.
    Filardi M; Pizza F; Martoni M; Vandi S; Plazzi G; Natale V
    Sleep Med; 2015 Jan; 16(1):126-30. PubMed ID: 25547035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1.
    Laberge L; Bégin P; Dauvilliers Y; Beaudry M; Laforte M; Jean S; Mathieu J
    J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):642-6. PubMed ID: 19211594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.